No predictive value of serum interleukin-6 and transforming growth factor-β1 in identifying patients with a first restenosis, recurrent restenosis or a history of restenosis

European Cytokine Network

Volumn 20, Issue 3, 2009, Pages 135-139

  Hudzik, Bartosz ^a   Szkodzinski, Janusz ^a   Romanowski, Wojciech ^a   Wilczek, Krzysztof ^a   Wojnar, Rafal ^a   Lekston, Andrzej ^a   Polonski, Lech ^a   Zubelewicz Szkodzinska, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Interleukin 6; Recurrent restenosis; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RESTENOSIS; STENOSIS; STENT;

CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70849112428     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0160     Document Type: Article

References (23)

1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med 1994; 331: 489-495 (Pubitemid 24256751)
2. Bhargava B, Karthikeyan G, Abizaid AS, et al. New approaches to preventing restenosis. BMJ 2003; 327: 274-279
3. Van Snick J. Interleukin-6 an overview. Annu Rev Immunol 1990; 8: 253-278
4. Wong GG, Clark SC. Multiple actions of IL-6 within a cytokine network. Immunol Today 1988; 9: 137-139
5. Marie C, Cavaillon JM. Negative feedback in inflammation. The role of anti-inflammatory cytokine. Bull Inst Pasteur 1997; 95: 141-154
6. Waltenberger J. Modulation of Growth Factor Action. Implications for the Treatment of Cardiovascular Diseases. Circulation 1997; 96: 4083-4094
7. Szkodzinski J, Blazelonis A, Wilczek K, et al. The role of Interleukin-6 and Transforming Growth Factor-β1 in predicting restenosis within stented infarct-related artery. Int J Immunopathol Pharmacol 2009; 22: 493-500.
8. Bauters C, Mc Fadden EP, Lablanche JM, et al. Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis. Circulation 1993; 88: 969-974
9. Jeong MH, Kim SH, Ahn YK. al. Predictive factors for the second restenosis after coronary interventions. Catheter Cardiovasc Interv 2000; 50: 34-39
10. Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-230 (Pubitemid 28064746)
11. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
12. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986; 314: 488-500.
13. Newman FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995; 92: 748-755
14. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874-877 (Pubitemid 26292834)
15. Ikeda U, Ito T, Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol 2001; 24: 701-704
16. Hojo Y, Ikeda U, Katsuki T, et al. Interleukin-6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 2000; 84: 83-87 (Pubitemid 30429230)
17. Suzuki T, Ishiwata S, Hasegawa K, et al. Raised interleukin 6 concentrations as a predictor of postangioplasty restenosis. Heart 2000; 83: 578. (Pubitemid 30316729)
18. Segev A, Kassam S, Buller CE, et al. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J 2004; 25: 1029-1035 (Pubitemid 38869421)
19. Gomma AH, Hirschfield GM, Gallimore Jr JR, et al. Preprocedural inflammatory markers do not predict restenosis after successful coronary stenting. Am Heart J 2004; 147: 1071-1077
20. Ward MR, Agrotis A, Kanellakis P, et al. Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting. Arterioscler Thromb Vasc Biol 2002; 22: 940-948 (Pubitemid 34655221)
21. Tamai H, Katoh K, Yamaguchi T, et al. The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). Am Heart J 2002; 143: 506-513 (Pubitemid 34185183)
22. Nikol S, Isner JM, Pickering JG, et al. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992; 90: 1582-1592
23. Chung IM, Gold HK, Schwartz SM, et al. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002; 40: 2072-2081